The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay. The agency approved the vaccine only for people 65 and older and those 12 and ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators ...

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The U.S. Department of Health and Human Services is reportedly planning to nix recommendations for pregnant women, teens, and ...

There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...